Skip to Main Content
Our Commitment to Diversity

REPRESENTATIVE EXPERIENCE

Francesco Carloni

Representing a global conglomerate in its proposed US$650 million acquisition of a chemical specialist company before the competent antitrust and FDI authorities.
Representing the French trade association for the fashion industry in the legislative process for the adoption of the proposal for a new Ecodesign for Sustainable Products Regulation (ESPR 2022/0095(COD)).
Representing a large consortium of privately held companies which together with other companies delisted and acquired control over a company in an all-cash transaction for an enterprise value of approximately US$10.9 billion before the Australian Commission and Consumer Commission, the Chile's competition authority, the State Administration for Market Regulation in China (SAMR), the Brazilian Competition Authority (CADE), the European Commission, the Taiwan Fair Trade Commission (TFTC), the Turkish Competition Authority, and the U.S. FTC. The transaction also requires post-closing filings in Egypt, Argentina, Indonesia and Canada (FDI).
Representing a global luxury brand with the review of its online T&C regarding its jewellery products in the EMEA.
Representing a global luxury brand with the design of its selective distribution in Europe and global distribution strategies.
Representing a global iconic brand in connection with the European Commission's investigation into alleged cartel behaviour in the fashion sector. We also assisted the brand with the dawn raids which took place mid-May 2022.
Representing a global luxury brand with the design of its selective distribution in Europe.
Representing a global technology company in its US$3.8 bn divestiture to MaxLinear before the U.S. FTC and SAMR in China.
Representing a global luxury brand with the design of its selective distribution in Europe.
Representing a global security services provider in connection with its US$3.2 bn acquisition of another electronic security provider before the European Commission, Canada, Colombia, U.S. FTC/DOJ.
Representing a cancer detection company as third-party intervener before the European Commission and the U.S. FTC in connection with Illumina’s US$8 bn proposed acquisition of Grail (2021-2022), the first ever case referred upwards to the Commission following the review of its approach to Article 22 EUMR.
Representing a global information technology in its US$2.75 bn acquisition of an enterprise asset management company before the U.S. Federal Trade Commission, the Brazilian Competition Authority (CADE), the Austrian Competition Authority, and the German Federal Cartel Office.
Representing a global luxury brand with the review of its online T&C regarding its fashion products globally.
Representing the Italian chamber for fashion in preparing its contributions to the European Commission’s consultation on Vertical Block Exemption Regulation (VBER).
Representing the French trade association for the fashion industry in preparing its contributions to the European Commission’s consultation on Vertical Block Exemption Regulation (VBER).
Representing a manufacturer of equipment for the wood/plywood industry in its US$325 million divestiture to a private equity before the U.S. FTC, Austrian Competition Authority, and the Russian Federal Anti-Monopoly Service.
Representing a global conglomerate before the European Commission in connection with remedies implementation of Elanco’s US$7.6 bn acquisition of Bayer Animal Health.
Representing a digital-marketing company in its US$500 million acquisition of a leading digital group.
Representing a global nuclear supplier in connection with the assessment and review of its long-standing JV regarding the European nuclear energy market in connection with exclusivity, licensing, and termination issues.
Representing one of the largest automotive associations in connection with the establishment of the automated driving system standard before the European Commission and competent competition authorities globally.
Representing a leading air carrier before the European Commission and the U.S. Department of Travel in connection with the unwinding of the Transatlantic c JV with Delta Airlines, Air France-KLM, and the new cooperation with Delta Airlines
Representing a global security services provider in connection with its acquisition of electronic security businesses in Germany, Portugal, Switzerland, Singapore, and India. 
Representing a pharmaceutical company in connection with its US$1.3 bn acquisition by another pharmaceutical group before the competent antitrust authorities globally.
Representing a company active in engineered materials, optoelectronic components, and optical system in its US$3.2 bn merger of another manufacturer of optical communication components and subsystems before the competent antitrust authorities globally.
Representing a company active in forklift trucks, warehouse equipment, and industrial trucks in connection with the global merger control aspects of its multi-million euro investment in a company active supplier of forklift.
Representing a company active in the packaging industry in connection with the global merger control aspects of its US$500 million acquisition of a company active in the packaging industry before the competent antitrust authorities.
Advising a luxury fashion group in connection with the implementation of its antitrust compliance program globally.
Representing a pharmaceutical company in connection with the JV between a multinational manufacturing company and a wholesale building materials supplier before the European Commission.
Representing a company active in the development, publication, and services of mobile and PC online games in connection with the global merger control aspects of its acquisition of a company active in the gaming industry before the competent antitrust authorities.
Representing a company active in the provisions of market research services globally in its acquisition of parts of the research business of another provider before the competent antitrust authorities globally.
Representing a media entertainment company in connection with Comcast/Sky before the European Commission.
Representing a pharmaceutical company in connection with CVC/Recordati before the European Commission.
Representing a company developing and marketing security and inspection systems in connection with the implementation of remedies in Smiths/Morpho before the European Commission and the US DoJ.
Representing an association representing the interests of travel distributors and global distribution systems in Lufthansa/Air Berlin assets before the European Commission.
Representing the holding company of a company distributing electrical equipment in its investment in a renewable energy company.
Representing a trade association active in the fashion sector in connection with the European Commission’s e-commerce sector inquiry and online issues.
Representing a national fashion federation in the European Commission’s e-commerce sector inquiry and online issues.
Representing a major Italian fashion group in the European Commission’s e-commerce sector inquiry.
Advising a major Italian fashion group and one of its brands in connection with distribution policy and antitrust compliance.
Advising a luxury fashion group in connection with distribution policy and antitrust compliance.
Advising a luxury goods company in connection with distribution policy and antitrust compliance.
Advising a sectorial professional association in connection with antitrust compliance.
Advising an Italian luxury men’s fashion house in connection with distribution policy and antitrust compliance.
Advising an Italian luxury menswear brand in connection with distribution policy and antitrust compliance.
Advising a trade association active in the fashion sector in connection with antitrust compliance.
Representing the two largest trade associations active in the fashion sector in connection with the European Commission’s review and evaluation of the EU rules on distribution agreements.
Representing a producer and distributor of specialty chemical materials in its joint venture with an investment intermediation company and an energy company before the European Commission.
Representing a company active in the manufacturing and distribution of automotive spare parts in its acquisition of a leading pan-European business-to-business distributor of car parts, before the European Commission. The enterprise value is US$1.1 bn.
Represented a global private equity firm and the founders of a leading pharmaceutical company in the areas of women’s health and endocrinology, in its acquisition by a global investment banking, securities and investment management firm, and a private equity investment company before the European Commission and a number of non-EU competition authorities.
Represented a French holding company in its $440 million acquisition of a luxury cruise-ship operator from a pan-European private equity investor involving multi-jurisdictional filings.
Represented a leading natural gas storage company in its proposed acquisition of a 50% stake in a JV active in the underground storage of natural gas.
Lead associate assisting in representation of a global provider of technology services to telecommunications companies’ $300 million acquisition of a California-based mobile network servicing company involving multi-jurisdictional filings (telecommunication services to MNOs) (e.g. Austria, Taiwan, Ukraine).
Lead associate assisting in representation of a multinational pharmaceutical company’s $4 bn acquisition of a generic drug maker involving multi-jurisdictional filings (e.g. Poland, Russia, South Africa, Ukraine).
Represented an operating company within a diversified global manufacturer with annual revenues of more than $8 bn, before the South Korean competition authority in its acquisition of a major engineered pumps manufacturer.
Represented private equity funds as third-party intervener in EU proceedings and assisted a leading systems for dialysis and extracorporeal blood purification company in its proposed acquisition of certain divested asset (medical equipment).
Lead associate assisting in representation of a global provider of technology services to telecommunications companies before the European Commission and acted as lead associate in representation before non-EU competition authorities (e.g., Argentina; Brazil; Colombia; Jersey; Taiwan; Ukraine) in connection with its €550 million acquisition of another global provider of technology services to telecommunications companies . Drafted Form RS, Form CO; worked closely with economists; engaged in remedies discussions with the Commission and prepared Form RM and Commitment schedules (Phase II clearance with remedies) (roaming services to MNOs).
Assisted the M&A department in the representation of a major diversified industrial, technology, and services group in its acquisition of the aviation business of an Italy-based manufacturer of aviation propulsion components and systems for civil and military aircraft, for $4.3 bn.
Lead associate assisting in representation of an Italian dairy group before the European Commission in connection with a French dairy company’ takeover bid worth €3.4 bn on 100% of its share capital. (Phase I clearance without conditions) (NB: the merger created one of the largest dairy groups).
Represented a global financial services provider and a private equity firm before the Italian Antitrust Authority in connection with several acquisitions (Phase I clearance (basic industries; services)).
Assisted in representation of a biocides company before French and German competition authorities in connection with a drugs industry supplier 's $1.4 bn acquisition of all of its outstanding shares (NB: the merger created one of the world's largest microbial control companies (biocides)).
Lead associate in representation of a global food and beverage company in its $39 bn disposal of its majority interest in a leading eye care company to a major pharmaceutical company. Drafted Form CO; engaged in remedies discussions with the Commission and prepared Form RM and Commitment schedules (Phase I clearance with remedies) (pharmaceuticals).
Assisted in representation of a global science-based healthcare company in its $41 bn merger with a global research-driven pharmaceutical company.  Drafted Form CO (Phase I clearance without remedies) (pharmaceuticals).
Represented a company active in the design, manufacturing, and marketing of construction, mining and agricultural machinery before the Italian Competition Authority in its acquisition of a South Korean seal manufacturer (Phase I clearance) (seal components).
Assisted in representation of a digital map provider, in its $8.1 bn acquisition by a provider of equipment, solutions, and services for electronic communications networks. One of the first vertical mergers being assessed under the Commission’s non-horizontal merger guidelines (Phase II clearance without remedies) (digital maps).
Assisted in representation of a major provider of computer software and operating system’s defense against the Statement of Objections and subsequent Letter of Facts in Commission’s 102 TFEU investigation in relation to alleged tying practices. Drafted sections of response to the Statement of Objections and Letter of Facts; prepared letters to the Hearing Officer (e.g., request for time extension, access to file, lifting of confidentiality (case settled in December 2009)) (high-tech).
Assisted in representation of a leading semiconductors company in a European Commission investigation into a complaint alleging abuse of a dominant position. Assess case file; drafted legal memoranda.
Assisted in representation of major international liner shipping company in European Commission investigation into container shipping transport services concerning alleged anti-competitive price signaling behavior.
Assisted in representation, access to file and response to Statement of Objections.
Assisted in representation, access to file and response to Statement of Objections, document review.
Assisted in representation, access to file and Statement of Objections, document review.
Assisted in representation of a global science-based healthcare company in complex sector inquiry seeking to examine the workings of competition in the European Commission’s pharmaceutical sector (NB: seconded to the company's headquarters to prepare response to Commission's first questionnaire).
Assisted an over-the-top media services company in connection with state aid issues before the European Commission.
Assisted in representation of an Italian shipping company against the Italian State's illegal measures granting unjustified berthing priority and lump-sum payment to another shipping company in the Gulf of Naples in its alleged capacity as the directly appointed operator of public service obligations.
Assisted in the representation of a global financial services company in the investigation in Mexico of one of its subsidiaries which is the second largest bank in Mexico (seconded in Mexico City for three weeks (June 2014)). Conducted interviews of certain employees and prepared an analysis of findings.
Advised a major Italian banking group, an international financial services provider in connection with the implementation of the prohibition of interlocking directorships in Italy.
Advising a major Italian banking group in connection with antitrust compliance, reportability, and merger control aspects of potential acquisitions.
Prepared and submitted a multinational law firm's response to the European Commission’s public consultation on non-controlling minority shareholding.
Prepared and submitted a multinational law firm's response to the Italian Competition Authority in connection with the proposed legislative change to the Italian merger control thresholds.
Part of a global law firm's team commenting on the "Best practices in antitrust proceedings and submission of economic evidence; Hearing Officers' guidance paper".
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel